After Gland, Chinese pharma giant Fosun eyes API maker Symbiotec

​​Symbiotec has been an acquisition target for other drug makers and PE players after the Indore-based company was put up for sale.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news